Organogenesis Holdings (ORGO) Depreciation & Amortization (CF) (2018 - 2026)

Organogenesis Holdings' Depreciation & Amortization (CF) history runs 9 years deep, the most recent figure standing at $4.2 million for Q1 2026.

• On a quarterly basis, Depreciation & Amortization (CF) rose 21.2% year-over-year to $4.2 million in Q1 2026; TTM through Mar 2026 was $16.0 million, a 14.35% increase from a year earlier, with the FY2025 full-year figure at $15.3 million, up 12.11% from the prior year.
• Depreciation & Amortization (CF) improved to $4.2 million in Q1 2026 per ORGO's latest filing, from $4.1 million in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $4.2 million in Q1 2026 and bottomed at $1.3 million in Q1 2022.
• The 5-year median for Depreciation & Amortization (CF) is $3.1 million (2024), against an average of $2.9 million.
• Across the five-year window, Depreciation & Amortization (CF) dropped 24.83% in 2022 and jumped 100.0% in 2023, its largest moves.
• Year by year, Depreciation & Amortization (CF) stood at $1.5 million in 2022, then jumped by 96.96% to $3.0 million in 2023, then rose by 21.23% to $3.6 million in 2024, then gained by 12.48% to $4.1 million in 2025, then gained by 2.66% to $4.2 million in 2026.
• Per Business Quant, the three latest ORGO Depreciation & Amortization (CF) figures stand at $4.2 million (Q1 2026), $4.1 million (Q4 2025), and $4.0 million (Q3 2025).